Gene · 140
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Psoriasis: a focus on upcoming oral formulations. | Expert Opin Investig Drugs | 2023 | 37507233 | PubTator, text mining | PubMed |
| Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning. | Front Genet | 2023 | 37465165 | PubTator, text mining | PubMed |
| The immunomodulatory role of IDO1-Kynurenine-NAD+ pathway in switching cold tumor microenvironment in PDAC. | Front Oncol | 2023 | 37456260 | PubTator, text mining | PubMed |
| Mitochondrial quality control and its emerging role in the pathogenesis of diabetic kidney disease. | Kidney Res Clin Pract | 2023 | 37448292 | PubTator, text mining | PubMed |
Identification of signaling pathways modifying human dopaminergic neuron development using a pluripotent stem cell-based high-throughput screening automated system: purinergic pathways as a proof-of-principle. | Front Pharmacol | 2023 | 37435497 | PubTator, text mining | PubMed |
| Role of the Sympathetic Nervous System in Mild Chronic Inflammatory Diseases: Focus on Osteoarthritis. | Neuroimmunomodulation | 2023 | 37429263 | PubTator, text mining | PubMed |
| The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. | Sci Immunol | 2023 | 37418547 | PubTator, text mining | PubMed |
| A2B adenosine receptor activation and modulation by protein kinase C. | iScience | 2023 | 37404375 | PubTator, text mining | PubMed |
| Evolutionary Shortcuts via Multinucleotide Substitutions and Their Impact on Natural Selection Analyses. | Mol Biol Evol | 2023 | 37395787 | PubTator, text mining | PubMed |
| Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A2A Adenosine Receptor Useful in Neurodegenerative Disorders. | Molecules | 2023 | 37375315 | PubTator, text mining | PubMed |
| A Pilot Cross-Sectional Study of Immunological and Microbiome Profiling Reveals Distinct Inflammatory Profiles for Smokers, Electronic Cigarette Users, and Never-Smokers. | Microorganisms | 2023 | 37374908 | PubTator, text mining | PubMed |
| Targeting Adenosine Signalling in Knee Chondropathy: The Combined Action of Polydeoxyribonucleotide and Pulsed Electromagnetic Fields: A Current Concept Review. | Int J Mol Sci | 2023 | 37373237 | PubTator, text mining | PubMed |
| A Preliminary Survey of Transfer RNA Modifications and Modifying Enzymes of the Tropical Plant Cocos nucifera L. | Genes (Basel) | 2023 | 37372467 | PubTator, text mining | PubMed |
| Investigation of adenosine A1 receptor-mediated β-arrestin 2 recruitment using a split-luciferase assay. | Front Pharmacol | 2023 | 37324481 | PubTator, text mining | PubMed |
| Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner. | Nat Commun | 2023 | 37291128 | PubTator, text mining | PubMed |
| ACDC: a general approach for detecting phenotype or exposure associated co-expression. | Front Med (Lausanne) | 2023 | 37275375 | PubTator, text mining | PubMed |
| Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation. | Front Pharmacol | 2023 | 37266145 | PubTator, text mining | PubMed |
| Crystal structure of adenosine A2A receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction. | Commun Chem | 2023 | 37264098 | PubTator, text mining | PubMed |
| "Dual Anta-Inhibitors" of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies. | Pharmaceuticals (Basel) | 2023 | 37259317 | PubTator, text mining | PubMed |
| Molecular treatment trajectories within psoriatic T lymphocytes: a mini review. | Front Immunol | 2023 | 37251381 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140/papers?page=8